Mengyao Ella Li

Senior Director of Investment, ZGC Capital Corporation

Dr. Ella Li currently serves as the head of Investment Department of ZGC Capital Corporation, leading ZGC’s team in investment and incubator operation. Ella has 15+ years of experience in pharmaceutical and biotechnology sectors and has rich investment experiences in therapeutic investment opportunities. She has also rich experiences in digital health, AI and IOT sectors. Prior to ZGC, she was with Beacon VP Capital where she focused on investment diligence in biotech and pharma companies. She also serves as board advisor and mentor in several major accelerators and startups.

 

Dr. Ella Li earned her B.S. and M.S. degrees from Peking University School of Pharmacy, and her Ph.D. from the University of Texas Health Science Centers. She completed her postdoctoral fellowship from Harvard Medical School, where she led five independent projects exploring novel therapeutic targets for metabolic disease. Ella has extensive publications in prestigious journals with IMF over 10 including Nature Communication, Cell Metabolism, Journal of Clinical Investigation, PNAS, Molecular Cell, Diabetes etc. with 300+ citations.